Stock PRTG PORTAGE BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Portage Biotech Inc.

Equities

PRTG

VGG7185A1286

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.2402 USD +1.35% Intraday chart for Portage Biotech Inc. -11.37% -86.80%
Apr. 15 Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives CI
Apr. 12 Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives CI

Evolution of the average Target Price on Portage Biotech Inc.

Price target over the last 5 years

History of analyst recommendation changes

fe6cdf449c14.S-uQpVpsdzYd887EG0M5sVQcxKsKKtwfAI-PTFuxUnA.HN389j0oPEFXx_6uVC11-TdXsf5mYpdRePe9CjHaJhF9raLgLy8aTyqAqQ~d73a15be9ae27ac6d22b2413e695e9d7

Analyst Recommendations on Portage Biotech Inc.

HC Wainwright Downgrades Portage Biotech to Neutral From Buy MT
HC Wainwright Cuts Price Target on Portage Biotech to $9 From $21, Maintains Buy Rating MT
Cantor Fitzgerald Adjusts Price Target on Portage Biotech to $11 From $16, Maintains Overweight Rating MT
HC Wainwright Adjusts Portage Biotech's Price Target to $21 From $22, Keeps Buy Rating MT
Oppenheimer Adjusts Portage Biotech Price Target to $18 From $26, Maintains Outperform Rating MT
HC Wainwright Adjusts Price Target on Portage Biotech to $22 From $32, Reiterates Buy Rating MT
Cantor Fitzgerald Adjusts Portage Biotech Price Target to $26 From $35, Maintains Overweight Rating MT
HC Wainwright Initiates Portage Biotech at Buy with $32 Price Target MT
PORTAGE BIOTECH : Oppenheimer Initiates Coverage on Portage Biotech With Outperform Rating, $30 Price Target MT
PORTAGE BIOTECH : B. Riley Starts Portage Biotech at Buy with $40 PT, Notes 'Significant' Upside Potential in Solid Tumor Markets MT
PORTAGE BIOTECH : Cantor Fitzgerald Starts Portage Biotech at Overweight With $35 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.2402 USD
Average target price
7 USD
Spread / Average Target
+2,814.24%
High Price Target
7 USD
Spread / Highest target
+2,814.24%
Low Price Target
7 USD
Spread / Lowest Target
+2,814.24%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Portage Biotech Inc.

HC Wainwright
Cantor Fitzgerald
Oppenheimer
B. Riley

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PRTG Stock
  4. Consensus Portage Biotech Inc.